Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Treatment for depression comorbid with dementia.

Baruch N, Burgess J, Pillai M, Allan CL.

Evid Based Ment Health. 2019 Nov;22(4):167-171. doi: 10.1136/ebmental-2019-300113. Epub 2019 Sep 26. Review.

PMID:
31558560
2.

[Dentist's satisfaction of continuing education: survey among dentists in Jerusalem].

Mersel A, Baruch N, Tayeb I, Mann J, Zini A.

Refuat Hapeh Vehashinayim (1993). 2017 Jan;34(1):53-66, 75. Hebrew.

PMID:
30699496
3.

Promoting early dementia diagnosis: a video designed by patients, for patients.

Baruch N, Allan CL, Cundell M, Clark S, Murray B.

Int Psychogeriatr. 2017 May;29(5):863-867. doi: 10.1017/S104161021600209X. Epub 2016 Dec 5.

PMID:
27916019
4.

Driving and dementia: a clinical update for mental health professionals.

Allan CL, Behrman S, Baruch N, Ebmeier KP.

Evid Based Ment Health. 2016 Nov;19(4):110-113. doi: 10.1136/eb-2016-102485. Epub 2016 Oct 20.

PMID:
27765792
5.

Proposed Approach for 4-Month Treatment of Culture-Negative Pulmonary Tuberculosis in Adults.

Hamada Y, Paulos L, Baruch NG, Cronin W.

Ann Am Thorac Soc. 2016 Sep;13(9):1657-8. doi: 10.1513/AnnalsATS.201604-302LE. No abstract available.

PMID:
27627478
6.

Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity.

Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T.

Mult Scler Relat Disord. 2016 Jul;8:136-40. doi: 10.1016/j.msard.2016.05.019. Epub 2016 May 31.

PMID:
27456889
7.

Identification and Characterization of a Novel Aspergillus fumigatus Rhomboid Family Putative Protease, RbdA, Involved in Hypoxia Sensing and Virulence.

Vaknin Y, Hillmann F, Iannitti R, Ben Baruch N, Sandovsky-Losica H, Shadkchan Y, Romani L, Brakhage A, Kniemeyer O, Osherov N.

Infect Immun. 2016 May 24;84(6):1866-1878. doi: 10.1128/IAI.00011-16. Print 2016 Jun.

8.

When communicable and non-communicable diseases collide.

Chaulk CP, Baruch NG.

Int J Tuberc Lung Dis. 2015 Jul;19(7):749. doi: 10.5588/ijtld.15.0454. No abstract available.

PMID:
26056096
9.

Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.

Baruch NF, O'Donnell EH, Glanz BI, Benedict RH, Musallam AJ, Healy BC, Rintell D, Chitnis T.

Mult Scler. 2016 Mar;22(3):354-61. doi: 10.1177/1352458515588781. Epub 2015 Jun 3.

PMID:
26041802
10.

Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years.

Benson LA, Healy BC, Gorman MP, Baruch NF, Gholipour T, Musallam A, Chitnis T.

Mult Scler Relat Disord. 2014 Mar;3(2):186-93. doi: 10.1016/j.msard.2013.06.004. Epub 2013 Jul 12.

PMID:
25878006
11.

An evaluation of the use of olanzapine pamoate depot injection in seriously violent men with schizophrenia in a UK high-security hospital.

Baruch N, Das M, Sharda A, Basu A, Bajorek T, Ross CC, Sengupta S, Larkin F, Young S.

Ther Adv Psychopharmacol. 2014 Oct;4(5):186-92. doi: 10.1177/2045125314531982.

12.

Nurturing syndrome in an elderly woman without dementia.

Baruch N, Somerville-Tyler CM, Bradley KM, Wilkinson P.

J Am Geriatr Soc. 2014 Mar;62(3):581-2. doi: 10.1111/jgs.12758. No abstract available.

PMID:
24628638
13.

Adverse incidents and patient safety - improving the learning experience of junior doctors.

Baruch N.

Clin Med (Lond). 2014 Feb;14(1):42-3. doi: 10.7861/clinmedicine.14-1-42.

15.

Pretreatment CA 15-3 levels do not predict disease-free survival in patients with advanced epithelial ovarian cancer.

Gemer O, Oustinov N, Gdalevich M, Dubnik S, Levy R, Yachnin A, Lavie O, Ben Baruch N, Ben Arie A.

Tumori. 2013 Mar-Apr;99(2):257-60. doi: 10.1700/1283.14201.

PMID:
23748823
16.

Prospective phase II study of neoadjuvant therapy with cisplatin, 5-fluorouracil, and bevacizumab for locally advanced resectable esophageal cancer.

Idelevich E, Kashtan H, Klein Y, Buevich V, Baruch NB, Dinerman M, Tokar M, Kundel Y, Brenner B.

Onkologie. 2012;35(7-8):427-31. doi: 10.1159/000340072. Epub 2012 Jul 6.

PMID:
22846974
17.

[The influence of medical art therapy on quality of life and compliance of medical treatment of patients with advanced heart failure].

Sela N, Baruch N, Assali A, Vaturi M, Battler A, Ben Gal T.

Harefuah. 2011 Feb;150(2):79-83, 209. Hebrew.

PMID:
22164930
18.

Demographic and clinical characteristics of malignant multiple sclerosis.

Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T.

Neurology. 2011 Jun 7;76(23):1996-2001. doi: 10.1212/WNL.0b013e31821e559d.

PMID:
21646626
19.

One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.

Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1125-31. doi: 10.1136/jnnp.2011.242115. Epub 2011 Mar 22.

PMID:
21429902
20.

Context influences contour integration.

Dakin SC, Baruch NJ.

J Vis. 2009 Feb 12;9(2):13.1-13. doi: 10.1167/9.2.13.

21.

Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.

Idelevich E, Greif F, Mavor E, Miller R, Kashtan H, Susmalian S, Ariche A, Brenner B, Baruch NB, Dinerman M, Shani A.

Chemotherapy. 2009;55(2):76-82. doi: 10.1159/000183732. Epub 2008 Dec 12.

PMID:
19077422
22.

Tuberculosis control in a large urban jail: discordance between policy and reality.

Rutz HJ, Bur S, Lobato MN, Baucom S, Bohle E, Baruch NG.

J Public Health Manag Pract. 2008 Sep-Oct;14(5):442-7. doi: 10.1097/01.PHH.0000333878.55572.ed.

PMID:
18708887
23.

Conjugates of unsaturated fatty acids with propylene glycol as potentially less-irritant skin penetration enhancers.

Ben-Shabat S, Baruch N, Sintov AC.

Drug Dev Ind Pharm. 2007 Nov;33(11):1169-75.

PMID:
18058312
24.

Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.

Idelevich E, Karminsky N, Dinerman M, Katsenelson RL, Zvi NB, Baruch NB, Biran H, Man S, Shani A.

Acta Oncol. 2007;46(3):324-9.

PMID:
17450467
25.

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.

Arch Intern Med. 2006 Sep 25;166(17):1863-70.

PMID:
17000943
26.

Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review.

Torgersen J, Dorman SE, Baruch N, Hooper N, Cronin W.

Clin Infect Dis. 2006 May 15;42(10):1375-82. Epub 2006 Apr 13.

PMID:
16619148
27.

Delayed tuberculosis diagnosis and tuberculosis transmission.

Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE.

Int J Tuberc Lung Dis. 2006 Jan;10(1):24-30.

PMID:
16466033
28.

Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state.

Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE.

Int J Tuberc Lung Dis. 2005 Sep;9(9):992-8.

PMID:
16158891
29.

Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis.

Golub JE, Bur S, Cronin WA, Gange S, Sterling TR, Oden B, Baruch N, Comstock GW, Chaisson RE.

Int J Tuberc Lung Dis. 2005 Apr;9(4):392-7.

PMID:
15832463
30.

Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.

Bur S, Golub JE, Armstrong JA, Myers K, Johnson BH, Mazo D, Fielder JF, Rutz H, Maltas G, McClain R, Cronin WA, Baruch NG, Barker LF, Benjamin W, Sterling TR.

Int J Tuberc Lung Dis. 2003 Dec;7(12 Suppl 3):S417-23.

PMID:
14677832
31.

Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?

Cronin WA, Golub JE, Lathan MJ, Mukasa LN, Hooper N, Razeq JH, Baruch NG, Mulcahy D, Benjamin WH, Magder LS, Strickland GT, Bishai WR.

Emerg Infect Dis. 2002 Nov;8(11):1271-9.

32.

Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D C, 1996-2000, linked to the homeless.

Lathan M, Mukasa LN, Hooper N, Golub J, Baruch N, Mulcahy D, Benjamin W, Cronin WA.

Emerg Infect Dis. 2002 Nov;8(11):1249-51.

33.

Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.

Cronin WA, Golub JE, Magder LS, Baruch NG, Lathan MJ, Mukasa LN, Hooper N, Razeq JH, Mulcahy D, Benjamin WH, Bishai WR.

J Clin Microbiol. 2001 Oct;39(10):3709-11.

34.

Improved tuberculosis infection control practices in Maryland acute care hospitals.

Fuss EP, Israel E, Baruch N, Roghmann MC.

Am J Infect Control. 2000 Apr;28(2):133-7.

PMID:
10760222
35.

One trial conditioning with apomorphine is blocked by cycloheximide.

Silverman PB, Baruch NP, Schultz KA.

Pharmacol Biochem Behav. 1989 Nov;34(3):663-4.

PMID:
2623022
36.

Carbamazepine (Tegretol)-induced thrombocytopenia.

Shoenfeld Y, Ben Baruch N, Livni E, Santo M, Pinkhas J.

Acta Haematol. 1982;68(1):74. No abstract available.

Supplemental Content

Loading ...
Support Center